Načítá se...
Recurrent Glioblastoma: Where we stand
Current first-line treatment regimens combine surgical resection and chemoradiation for Glioblastoma that provides a slight increase in overall survival. Age on its own should not be used as an exclusion criterion of glioblastoma multiforme (GBM) treatment, but performance should be factored heavily...
Uloženo v:
| Vydáno v: | South Asian J Cancer |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772393/ https://ncbi.nlm.nih.gov/pubmed/26981507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.175953 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|